clinical trial · NCT06178783
A Study of the Palatability and Acceptability of Different Brensocatib Oral Liquid Formulations in Healthy Participants
Healthy VolunteersBrensocatib
brief summary
The primary purpose of this study is to assess the palatability and compare acceptability of brensocatib oral solutions.
started
Dec 27, 2023
primary completion
Jan 4, 2024
completion
Jan 4, 2024
last updated
Jan 22, 2024
official title
A Phase 1, Double-blind, Randomized, Single-center Study to Assess the Palatability and Acceptability of Different Brensocatib Oral Liquid Formulations in Healthy Subjects
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol